Methenamine is as effective as antibiotics at preventing urinary tract infectionsBMJ 2023; 380 doi: https://doi.org/10.1136/bmj.p72 (Published 17 January 2023) Cite this as: BMJ 2023;380:p72
- Helen Saul, editor in chief1,
- Brendan Deeney, science writer1,
- Samantha Cassidy, science writer1,
- Jemma Kwint, senior research fellow1 ,
- Chris Harding, consultant urological surgeon and professor of urology2
- Correspondence to H Saul
Harding C, Mossop H, Homer T, et al. Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial. BMJ 2022;376:e068229.
To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/methenamine-as-good-as-antibiotics-preventing-urinary-tract-infections/
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: none.
Further details of The BMJ policy on financial interests are here: https://www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists/declaration-competing-interests
All authors contributed to the development and review of this summary, as part of the wider NIHR Alerts editorial team.
More summaries of NIHR research are available at: https://evidence.nihr.ac.uk/alerts/
Disclaimer: NIHR Alerts are owned by the Department of Health and Social Care and are made available to The BMJ under licence. NIHR Alerts report and comment on health and social care research but do not offer any endorsement of the research. The NIHR assumes no responsibility or liability arising from any error or omission or from the use of any information contained in NIHR Alerts.
Permission to reuse these articles should be directed to NIHRAlerts@nihr.ac.uk